Pivekimab

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Pivekimab

Sep 11, 2024, 09:16 | Insight

Naveen Pemmaraju: Pivekimab sunirine in relapsed or refractory acute myeloid leukaemia

Naveen Pemmaraju shared a post on X about a recent paper by Naval Daver et…

Mar 10, 2024, 12:31 | Drugs

Fadi Haddad: P1/2 study of pivekimab

Fadi Haddad, Assistant Professor, Leukemia Department MD Anderson Cancer Center, Houston, shared a post on X/Twitter:…

Jul 4, 2023, 10:34 | Stories

Interim analysis of Pivekimab sunirine for patients with BPDCN - Naveen Pemmaraju

I recently had the honor of delivering an oral presentation on our international group’s clinical…

All: 3 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023